Closing Bell: Knight Therapeutics Inc down on Tuesday (GUD)

Today, Knight Therapeutics Inc shares closed at $5.79 after opening the day at $5.88. prices ranged from a low of $5.75 to a high of $5.88.

Share prices slipped -1.19 percent from the previous day's close of $5.86.

Today across North America, the TSX Composite closed 0.34% at 22751.68, the S&P 500 closed 0.28% at 5631.22, the Dow Jones Industrial Average closed 0.53% at 40211.72 and the Nasdaq Composite closed 0.40% at 18472.57.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

A total of 34,577 shares was traded during the session, with total trades of 237, with an average volume of 46,395 over the last 5 days.

Trading across the entire TSX saw 4,226 price advancers against 1,023 declines and 82 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, in the last 52 weeks, Knight Therapeutics Inc's shares have boosted 18.65 percent, while in 2024, they have advanced 11.56%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $594.06 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..